Prelude Capital Management, LLC Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021
SELL
$61.35 - $90.47 $184,050 - $271,410
-3,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$43.82 - $85.37 $61,348 - $119,518
1,400 Added 87.5%
3,000 $230,000
Q2 2020

Aug 14, 2020
BUY
$26.12 - $43.27 $15,672 - $25,962
600 Added 60.0%
1,600 $69,000
Q1 2020

May 15, 2020
BUY
$20.56 - $63.12 $20,560 - $63,120
1,000 New
1,000 $29,000

Others Institutions Holding ARWR

# of Institutions
294
Shares Held
90.8M
Call Options Held
155K
Put Options Held
426K
View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

ARWR Quotes by TradingView
  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.07B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email